Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 17;38:205. doi: 10.1186/s13046-019-1203-2

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — High expression of Ajuba predicts poor prognosis in PDAC. a Expression pattern of Ajuba in paired human PDAC specimens (cancerous vs. adjacent tissue) based on intensity and percentage. b Representative images of PDAC tissues with weak/moderate/strong Ajuba expression. Statistics of the IHC staining of 80 cases of the PDAC specimens on TMA chips. Only IHC scores ≥4 point (++) was considered as high. Bar: 20 μm. c High level of Ajuba is positively associated with TNM stage and tumor volumes. d Survival analysis of patients with PDAC by Kaplan–Meier plots and log-rank tests